Q4124 identifies Oasis Tri-Layer Wound Matrix. Q4126 is for Memoderm, DermaTranZ, or InteguP.
On this page
CMS RVU26D · Effective 2026-10-01
Q4126 Wound matrix Medicare reimbursement rates in Nebraska
Q4126 identifies Memoderm, DermaTranZ, or InteguP material furnished for wound coverage and reported with the primary procedure applying the product. Compare Q4126 office and facility rates across CMS payment localities in Nebraska.
Amounts below use the non-QP conversion factor for participating physicians. These are base physician payments before claim-level adjustments, not patient costs or total hospital charges.
What does Medicare pay for Q4126 in Nebraska?
Nebraska has 1 payment locality in this comparison. Use the service location to choose the applicable amount. These are the supported base rates for the payment area shown below, using the same CMS release.
Office / nonfacility
$117.46
1 of 1 localities have a supported rate.
Payment area: Nebraska
One mapped payment locality.
Facility setting
No supported rate
These are locality ranges, not averages or address-specific quotes. A facility-setting amount covers the physician service; it does not include a hospital’s separate bill. Choose a locality below to inspect its calculation, compare other payment areas, or price a percentage of Medicare.
Skin substitute
About Q4126: Memoderm wound substitute supply
Q4126 identifies Memoderm, DermaTranZ, or InteguP material furnished for wound coverage and reported with the primary procedure applying the product.
Q4126 identifies the supply of Memoderm, DermaTranZ, or InteguP, products in the skin-substitute and wound-matrix category. It is associated with wound-care procedures in which a clinician places the selected material over a prepared wound bed. Wound-care physicians, surgeons, and other clinicians who treat wounds may furnish it in office or hospital settings. The code represents the named product, not a general wound assessment or the clinician’s application work.
Report Q4126 only when one of these products was supplied, and document the product, wound site, amount used, and related primary procedure. CMS identifies it as an add-on code: it must be billed with a primary procedure and is paid within that procedure’s global period. CMS also classifies it as technical-component-only, with interpretation covered by a separate code. Do not report Q4126 for another matrix merely because it serves a similar wound-care purpose.
CMS billing rules for Q4126
- Global period
- Add-on code: billed only together with a primary procedure and paid within that procedure's global period.
- Professional and technical components
- Technical-component-only code: a separate code covers interpretation.
Where the value comes from
- Work RVU0.00 · 0%
- Practice expense (office) RVU3.81 · 100%
- Malpractice RVU0.00 · 0%
This summary was written with AI assistance from CMS physician fee schedule data and checked against the CMS billing rules shown here. Rates on this page come directly from CMS files.
Q4126 compared with similar codes
Office rates for Nebraska, from the same CMS release.
Q4127 identifies Talymed; Q4126 identifies the Memoderm, DermaTranZ, and InteguP products.
Q4122 identifies Dermacell AWM. Use Q4126 only for its named products, not as a general code for wound matrices.
Compare Q4126 by payment locality
Find the payment area for your service address, then open its rate page for calculation inputs, release history and the percentage-of-Medicare tool. A city may cross payment-area boundaries; the ZIP lookup above helps resolve the location.
1 of 1 payment localities
Nebraska →
Office / nonfacility
$117.46
Facility
Unavailable
Need rates for a whole code list?
Fee-sheet and API access are in early access. Tell us which codes and locations your team needs.
How this local rate is calculated
Each RVU component is multiplied by its own geographic practice cost index (GPCI). The three adjusted components are added, then multiplied by the conversion factor. These are the inputs used for Q4126 in Nebraska.
PPRRVU2026_Oct_nonQPP.csv
18,222
- Code
- Q4126
- Physician work
- 0.00
- Practice expense
- 3.81
- Malpractice
- 0.00
GPCI2026.csv
72
- Locality
- Nebraska
- Physician work
- 1.000
- Practice expense
- 0.923
- Malpractice
- 0.378
| Component | RVU | Locality factor | Adjusted |
|---|---|---|---|
| Physician work | 0.00 | × 1.000 | 0.0000 |
| Practice expense | 3.81 | × 0.923 | 3.5166 |
| Malpractice | 0.00 | × 0.378 | 0.0000 |
| Total RVUs | 3.5166 | ||
| Conversion factor | × 33.4009 | ||
Office / nonfacility rate, Nebraska$117.46
Explore RVUs, geographic factors and the full formula
Office / nonfacility
| Component | RVU | Local GPCI |
|---|---|---|
| Work | 0 | 1 |
| Practice expense | 3.81 | 0.923 |
| Malpractice | 0 | 0.378 |
(0 × 1 + 3.81 × 0.923 + 0 × 0.378) × $33.4009 = $117.46
The office and facility calculations use their respective practice-expense RVUs. The facility amount here is the physician fee, not a separate hospital or facility bill.
Q4126 billing questions
When should a claim use Q4126 rather than another wound-matrix code?
Use Q4126 when the product furnished is Memoderm, DermaTranZ, or InteguP. A similar purpose does not make another product reportable under this code.
Can Q4126 be billed by itself?
No. CMS identifies it as an add-on code that must be reported with a primary procedure.
How does the global-period rule affect Q4126?
CMS pays Q4126 within the primary procedure’s global period. Report it with the primary procedure rather than as a standalone service.
What documentation supports reporting Q4126?
Document which named product was furnished, the wound site, the amount used, and the related primary procedure.
Does Q4126 include interpretation?
CMS classifies Q4126 as technical-component-only; a separate code covers interpretation.
Where these rates come from
FeeBase calculates base physician payments from CMS work, practice-expense, and malpractice RVUs, adjusted by each locality’s geographic indices and the applicable conversion factor. Unavailable or separately priced services are labeled rather than assigned a made-up amount.
Source: RVU26D. Effective 2026-10-01 through the day before 2027-01-01.
